[1]徐巧笑,胡振斌,莫莎莎,等.从“虚、毒、瘀”浅谈原发性肝癌病机和治疗[J].陕西中医,2023,(10):1431-1434.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.022]
　XU Qiaoxiao,HU Zhenbin,MO Shasha,et al.Discussion on pathogenesis and treatment of primary liver cancer from the perspective of “deficiency,poison,and blood stasis”[J].,2023,(10):1431-1434.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.022]
点击复制

从“虚、毒、瘀”浅谈原发性肝癌病机和治疗
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年10期
页码:
1431-1434
栏目:
学术探讨
出版日期:
2023-10-05

文章信息/Info

Title:
Discussion on pathogenesis and treatment of primary liver cancer from the perspective of “deficiency,poison,and blood stasis”
作者:
徐巧笑1; 胡振斌2; 莫莎莎1; 张 臻1
(1.广西中医药大学研究生院,广西 南宁 530004; 2.广西中医药大学第一附属医院,广西 南宁 530022)
Author(s):
XU Qiaoxiao; HU Zhenbin; MO Shasha; ZHANG Zhen
(Graduate School,Guangxi University of Traditional Chinese Medicine,Nanning 530004,China)
关键词:
原发性肝癌;  虚;  毒;  瘀;  病机观
Keywords:
Primary liver cancer;  Virtual;  Poison;  Blood stasis;  Pathogenesis view
分类号:
R 735.7
DOI:
DOI:10.3969/j.issn.1000-7369.2023.10.022
文献标志码:
A
摘要:
原发性肝癌(PLC)是我国常见的恶性肿瘤,预后极差,中医学认为虚毒瘀致病是阐释PLC发生、发展的重要理论,机体正气亏耗、外邪入侵所致气血阴阳失调,脏腑代谢等功能失常,痰浊、瘀血、癌毒内生结聚肝内形成肿块而发本病。现代医学则认为免疫微环境是正气亏虚的延伸,且炎症微环境、肿瘤外泌体、肠道菌群紊乱均为癌毒重要来源,现从“病机观”及“治疗观”出发,在阐述肝癌病机的同时对其治疗进行深度剖析,探讨瘀、毒、虚在原发性肝癌中的致病机制及以攻补兼施、扶正祛邪为纲的治法治则,提高临床思辨能力,为中医治疗肝癌,改善肝癌患者临床症状,提高其生活质量提供新的思路。
Abstract:
Primary liver cancer(PLC)is a common malignant tumor in China,with extremely poor prognosis.Traditional Chinese medicine believes that the pathogenesis of deficiency,toxin,and stasis is an important theory to explain the occurrence and development of PLC.It is mainly related to the depletion of vital energy in the body,the imbalance of qi,blood,yin,and yang caused by the invasion of external pathogens,dysfunction of viscera metabolism,and the formation of tumors in the liver caused by phlegm,blood stasis,and cancer toxin.Modern medicine believes that the immune microenvironment is an extension of the deficiency of vital energy,and that the inflammatory microenvironment,tumor secretions,and advocacy of bacterial flora disorders are important sources of cancer toxins.Starting from the “pathogenesis view” and the “treatment view”,this article elaborates on the pathogenesis of liver cancer while conducting a deep analysis of its treatment,exploring the pathogenic mechanism of blood stasis,toxin,and deficiency in primary liver cancer and the treatment principles based on both attacking and reinforcing,and strengthening the body and eliminating pathogenic factors,improve clinical thinking ability,provide new ideas for treating liver cancer with traditional Chinese medicine,improve clinical symptoms of liver cancer patients,and improve their quality of life.

参考文献/References:

[1] Petrick JL,Florio AA,Znaor A,et al.International trends in hepatocellular carcinoma incidence,1978-2012[J].Int J Cancer,2020,147(2):317-330.
[2] Llovet JM,Kelley RK,Villanueva A,et al.Hepatocellular carcinoma[J].Nat Rev Dis Primers,2021,7(1):6.
[3] 谭 健,关洪全,吴艳梅,等.试论中医脾肾学说与免疫细胞的发育及免疫功能[J].辽宁中医杂志,2016,43(9):1875-1877.
[4] 韩钦芮,符秀琼,禹志领,等.肿瘤微环境的脾虚本质探讨[J].中医杂志,2014,55(4):292-294,298.
[5] 陈锦芳,张桂英.慢性乙型肝炎肝郁脾虚证TNF-α、IL-6水平研究[J].福建中医学院学报,2009,19(4):15-16.
[6] Wang M,Zhao J,Zhang L,et al.Role of tumor microenvironment in tumorigenesis[J].J Cancer,2017,8(5):761-773.
[7] 刘娇萍,袁昌劲,曹继刚,等.从“象思维”探讨对肿瘤微环境的中医认识[J].时珍国医国药,2018,29(11):2723-2725.
[8] 季兴祖,周敏华,刘忠达,等.吴玉生辨治肝癌经验[J].浙江中西医结合杂志,2019,29(1):2-5.
[9] 庞 莉,袁 刘,葛信国.肿瘤炎性微环境与中医阴阳平衡的关系[J].中医杂志,2018,59(21):1832-1835.
[10] 胡 锐,周小舟,冯文杏,等.肝癌免疫微环境辨证论治传承及创新和发展研究进展[J].中西医结合肝病杂志,2021,31(5):473-476.
[11] 曾普华.从炎性微环境探析肿瘤恶液质的“癌毒致虚”病机观[J].陕西中医,2021,42(8):987-990,1137.
[12] Jiang X,Wang J,Deng X,et al.The role of microenvironment in tumor angiogenesis[J].J Exp Clin Cancer Res,2020,39(1):204.
[13] 张 雨,王志宇,王 能.肿瘤炎症微环境的中医属性及治则研究[J].世界中医药,2022,17(6):874-878.
[14] 程海波.癌毒病机理论探讨[J].中医杂志,2014,55(20):1711-1715.
[15] 吴俊成,徐铭益.外泌体与肝脏疾病的关系[J].临床肝胆病杂志,2017,33(9):1815-1819.
[16] 唐幸林子,王志宇,王 能.基于癌毒病机理论探讨外泌体对肿瘤及肿瘤微环境的交互作用[J].中华中医药杂志,2021,36(11):6770-6774.
[17] 孔怡琳,张玉佩.肝癌“瘀毒”病机与肠道微环境关系刍议[J].中国医药指南,2022,20(21):113-116.
[18] 高德慧,刘寨东.基于肝藏象理论的肿瘤微环境视角下肝肿瘤中医证治[J].陕西中医,2020,41(9):1282-1284.
[19] 姜 涛,朱爱松,杨丹倩,等.肿瘤“瘀毒”病机理论诠释[J].浙江中医药大学学报,2021,45(3):229-231,239.
[20] 李瀚旻.肝癌的肝再生微环境的研究进展及展望[J].世界华人消化杂志,2018,26(26):1529-1536.
[21] 周 灏,刘丽丽,施 美,等.徐经世国医大师扶正祛邪治疗肝癌经验总结[J].中西医结合肝病杂志,2022,32(2):106-109.
[22] 陆鑫熠,任建琳,吕 祥,等.基于“络病学说”分析虫类药在肿瘤患者治疗中的应用[J].世界中医药,2020,15(6):938-944,948.
[23] 周 颖,殷东风,高 宏,等.以扶正祛邪理论指导原发性肝癌的治疗[J].内蒙古中医药,2021,40(5):138-139.
[24] 牛玉清,杨 冰,王 丽,等.抗肝癌中药作用机制研究进展[J].中医肿瘤学杂志,2021,3(6):88-96.
[25] 汪 姣,包 良,杜吉雅,等.基于网络药理学和体外验证实验探索斑蝥素治疗肝癌的作用机制[J].中医药信息,2022,39(12):21-26,34.
[26] 徐小娟,周志涵,毛 宇,等.山慈菇多糖对H22肝癌小鼠IL-2及p53蛋白表达的影响[J].食品研究与开发,2016,37(18):6-10.
[27] 李索咪,徐辉辉,朱均晶,等.基于网络药理学探讨白花蛇舌草-半枝莲抗肝细胞癌的作用机制[J].浙江中医药大学学报,2020,44(11):1113-1123.
[28] 张智岩,张 玥.抗肿瘤中药有效成分研究进展[J].中国中医药现代远程教育,2017,15(21):159-160.
[29] 黄旭晖,王昌俊.活血化瘀中药干预肿瘤血管新生的研究进展[J].广东医学,2012,33(4):550-552.
[30] 史传文,龚继勇,刘福利,等.活血化淤中药干预肿瘤乏氧微环境在侵袭转移方面的研究进展[J].肿瘤防治研究,2009,36(12):1082-1084.

相似文献/References:

[1]乔喜婷,王 昊△,杨 林,等.复元活血汤合化积丸联合肝动脉栓塞化疗术治疗原发性肝癌临床研究*[J].陕西中医,2019,(8):998.
　QIAO Xiting,WANG Hao,YANG Lin,et al.Fuyuan Huoxue decoction plus Huaji pills and hepatic artery embolization in the treatment of primary liver cancer[J].,2019,(10):998.
[2]冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机*[J].陕西中医,2020,(2):217.
　FENG Jun,LIU Jianhe,RAN Junning,et al.Discussion on the pathogenesis of atherosclerosis from phlegm,blood stasis and asthenia[J].,2020,(10):217.
[3]李 丹,赵 飞,王树庚.疏肝健脾散结汤联合肝动脉插管化疗栓塞术治疗原发性肝癌疗效研究[J].陕西中医,2021,(6):728.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.012]
　LI Dan,ZHAO Fei,WANG Shugeng.Effect of Shugan Jianpi Sanjie decoction combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer[J].,2021,(10):728.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.012]
[4]项 燕,李 瑞,谢依璇,等.针灸从“虚、郁、瘀”论治产后腰痛[J].陕西中医,2022,(1):90.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.022]
[5]许 辉,仇 杰,陈 中,等.仇湘中从“虚、瘀、痰”论治老年性膝骨关节炎经验[J].陕西中医,2022,(9):1272.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.030]
　XU Hui,QIU Jie,CHEN Zhong,et al.Qiu Xiangzhong's experience in treating senile knee osteoarthritis from “Xu Yu Tan”[J].,2022,(10):1272.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.030]
[6]赵培西,许建秦,袁 彬,等.扶正抗癌方治疗肝癌肝郁脾虚瘀毒证临床研究[J].陕西中医,2022,(12):1746.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.022]
[7]周 林,肖 康,夏建辉.八珍汤加减辅助治疗原发性肝癌疗效及对患者外周血Th17/Treg平衡和不良反应的影响[J].陕西中医,2023,(9):1216.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.013]
　ZHOU Lin,XIAO Kang,XIA Jianhui.Effect of modified Bazhen decoction adjuvant therapy on peripheral blood Th17/Treg balance and adverse reactions in patients with primary liver cancer[J].,2023,(10):1216.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.013]
[8]吉 银,戴 铭,王振常,等.逍遥散合大黄虫丸治疗原发性肝癌经肝动脉化疗栓塞术后气滞血瘀型疗效研究[J].陕西中医,2024,(2):187.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.008]
　JI Yin,DAI Ming,WANG Zhenchang,et al.Treatment of primary hepatocellular carcinoma qi stagnation and blood stasis type patients after TACE with Xiaoyao San combined with Dahuang Zhechong pill[J].,2024,(10):187.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.008]
[9]蒋凤霞,郭鑫宇,高 珊,等.基于“肺朝百脉主治节”理论探讨慢性萎缩性胃炎证治[J].陕西中医,2024,(6):808.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.018]
　JIANG Fengxia,GUO Xinyu,GAO Shan,et al.Evidence and treatment of chronic atrophic gastritis based on the theory of “convergence of vessels in the lung” and “lung governing coordinative activities of viscera”[J].,2024,(10):808.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.018]
[10]李俊漪,徐 剑.龙胆泻肝汤对原发性肝癌肝动脉栓塞化疗术后患者肝功能及肿瘤标志物的影响研究[J].陕西中医,2024,(10):1353.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.012]
　LI Junyi,XU Jian.Longdan Xiegan decoction on liver function and tumor markers in patients with PHC after TACE[J].,2024,(10):1353.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.012]

备注/Memo

备注/Memo:
基金项目:国家科技重大专项课题子课题(2018ZX0725505-002)
更新日期/Last Update: 2023-10-09